{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T23:19:14Z","timestamp":1787872754275,"version":"build-2784847793"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T00:00:00Z","timestamp":1781308800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T00:00:00Z","timestamp":1787875200000},"content-version":"vor","delay-in-days":76,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Youth Science Fund of Xinjiang Uygur Autonomous Region Natural Science Foundation","award":["2024D01C339"],"award-info":[{"award-number":["2024D01C339"]}]},{"name":"Youth Project of Open Project of Key Laboratory of the Ministry of Education on \"Research on High incidence Diseases in Xinjiang Region\"","award":["2024C02"],"award-info":[{"award-number":["2024C02"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-57503-4","type":"journal-article","created":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T09:45:13Z","timestamp":1781343913000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["SPP1-positive myeloid cell subpopulations associated with resistance to PD-1\/L1 immunotherapy in lung adenocarcinoma"],"prefix":"10.1038","volume":"16","author":[{"given":"Ran","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cancan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomei","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinxia","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,13]]},"reference":[{"issue":"3","key":"57503_CR1","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1016\/j.gendis.2022.07.023","volume":"10","author":"H Padinharayil","year":"2023","unstructured":"Padinharayil, H. et al. Non-small cell lung carcinoma (NSCLC): Implications on molecular pathology and advances in early diagnostics and therapeutics. Genes Dis. 10 (3), 960\u2013989 (2023).","journal-title":"Genes Dis."},{"issue":"49","key":"57503_CR2","doi-asserted-by":"publisher","first-page":"e32217","DOI":"10.1097\/MD.0000000000032217","volume":"101","author":"B Wu","year":"2022","unstructured":"Wu, B. et al. Prognostic factors and survival prediction for patients with metastatic lung adenocarcinoma: A population-based study. Med. (Baltim). 101 (49), e32217 (2022).","journal-title":"Med. (Baltim)."},{"key":"57503_CR3","doi-asserted-by":"publisher","first-page":"1515748","DOI":"10.3389\/fimmu.2025.1515748","volume":"16","author":"A De Lucia","year":"2025","unstructured":"De Lucia, A. et al. Non-small cell lung cancer and the tumor microenvironment: making headway from targeted therapies to advanced immunotherapy. Front. Immunol. 16, 1515748 (2025).","journal-title":"Front. Immunol."},{"key":"57503_CR4","doi-asserted-by":"publisher","first-page":"175883592312250","DOI":"10.1177\/17588359231225036","volume":"16","author":"J Chen","year":"2024","unstructured":"Chen, J. et al. Efficacy of immunotherapy in patients with oncogene-driven non-small-cell lung cancer: a systematic review and meta-analysis. Ther. Adv. Med. Oncol. 16, 17588359231225036 (2024).","journal-title":"Ther. Adv. Med. Oncol."},{"key":"57503_CR5","doi-asserted-by":"publisher","first-page":"1366260","DOI":"10.3389\/fimmu.2024.1366260","volume":"15","author":"Y Xiang","year":"2024","unstructured":"Xiang, Y. et al. Mechanisms of resistance to targeted therapy and immunotherapy in non-small cell lung cancer: promising strategies to overcoming challenges. Front. Immunol. 15, 1366260 (2024).","journal-title":"Front. Immunol."},{"key":"57503_CR6","doi-asserted-by":"publisher","first-page":"1349502","DOI":"10.3389\/fimmu.2024.1349502","volume":"15","author":"Y Wu","year":"2024","unstructured":"Wu, Y., Yu, G., Jin, K. & Qian, J. Advancing non-small cell lung cancer treatment: the power of combination immunotherapies. Front. Immunol. 15, 1349502 (2024).","journal-title":"Front. Immunol."},{"issue":"10","key":"57503_CR7","doi-asserted-by":"publisher","first-page":"741","DOI":"10.3390\/cells14100741","volume":"14","author":"AF Saeed","year":"2025","unstructured":"Saeed, A. F. & Tumor-Associated Macrophages Polarization, Immunoregulation, and Immunotherapy. Cells 14 (10), 741 (2025).","journal-title":"Cells"},{"issue":"5","key":"57503_CR8","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.7150\/ijbs.106275","volume":"21","author":"H Tan","year":"2025","unstructured":"Tan, H. et al. Harnessing Macrophages in Cancer Therapy: from Immune Modulators to Therapeutic Targets. Int. J. Biol. Sci. 21 (5), 2235\u20132257 (2025).","journal-title":"Int. J. Biol. Sci."},{"issue":"1","key":"57503_CR9","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/s12943-025-02287-w","volume":"24","author":"X Cui","year":"2025","unstructured":"Cui, X., Liu, S., Song, H., Xu, J. & Sun, Y. Single-cell and spatial transcriptomic analyses revealing tumor microenvironment remodeling after neoadjuvant chemoimmunotherapy in non-small cell lung cancer. Mol. Cancer. 24 (1), 111 (2025).","journal-title":"Mol. Cancer"},{"issue":"1","key":"57503_CR10","doi-asserted-by":"publisher","first-page":"4388","DOI":"10.1038\/s41467-024-48700-8","volume":"15","author":"M De Zuani","year":"2024","unstructured":"De Zuani, M. et al. Single-cell and spatial transcriptomics analysis of non-small cell lung cancer. Nat. Commun. 15 (1), 4388 (2024).","journal-title":"Nat. Commun."},{"key":"57503_CR11","doi-asserted-by":"publisher","first-page":"1554871","DOI":"10.3389\/fimmu.2025.1554871","volume":"16","author":"J Zhang","year":"2025","unstructured":"Zhang, J. et al. Recent advances in biomarkers for predicting the efficacy of immunotherapy in non-small cell lung cancer. Front. Immunol. 16, 1554871 (2025).","journal-title":"Front. Immunol."},{"issue":"3","key":"57503_CR12","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1002\/med.21765","volume":"41","author":"H Sadeghi Rad","year":"2021","unstructured":"Sadeghi Rad, H. et al. Understanding the tumor microenvironment for effective immunotherapy. Med. Res. Rev. 41 (3), 1474\u20131498 (2021).","journal-title":"Med. Res. Rev."},{"issue":"5","key":"57503_CR13","doi-asserted-by":"publisher","first-page":"e011636","DOI":"10.1136\/jitc-2025-011636","volume":"13","author":"GD Kim","year":"2025","unstructured":"Kim, G. D. et al. Single-cell RNA sequencing of baseline PBMCs predicts ICI efficacy and irAE severity in patients with NSCLC. J. Immunother Cancer. 13 (5), e011636 (2025).","journal-title":"J. Immunother Cancer"},{"issue":"3","key":"57503_CR14","doi-asserted-by":"publisher","first-page":"e1613","DOI":"10.1002\/ctm2.1613","volume":"14","author":"X Lin","year":"2024","unstructured":"Lin, X. et al. Immune-related adverse events in non-small cell lung cancer: Occurrence, mechanisms and therapeutic strategies. Clin. Transl Med. 14 (3), e1613 (2024).","journal-title":"Clin. Transl Med."},{"issue":"7","key":"57503_CR15","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/s41571-025-01021-1","volume":"22","author":"Z Rahal","year":"2025","unstructured":"Rahal, Z., El Darzi, R., Moghaddam, S. J., Cascone, T. & Kadara, H. Tumour and microenvironment crosstalk in NSCLC progression and response to therapy. Nat. Rev. Clin. Oncol. 22 (7), 463\u2013482 (2025).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"57503_CR16","doi-asserted-by":"publisher","first-page":"1568556","DOI":"10.3389\/fimmu.2025.1568556","volume":"16","author":"Z Wang","year":"2025","unstructured":"Wang, Z., Wang, J., Wang, S., Xu, W. & Zhang, Y. Case Report: FAP(+) fibroblasts and SPP1(+) macrophages in SMARCA2-deficient while SMARCA4-preserved poorly differentiated lung adenocarcinoma: two case reports and multi-omics analysis. Front. Immunol. 16, 1568556 (2025).","journal-title":"Front. Immunol."},{"issue":"1","key":"57503_CR17","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1038\/s41588-024-01998-y","volume":"57","author":"Y Yan","year":"2025","unstructured":"Yan, Y. et al. Multi-omic profiling highlights factors associated with resistance to immuno-chemotherapy in non-small-cell lung cancer. Nat. Genet. 57 (1), 126\u2013139 (2025).","journal-title":"Nat. Genet."},{"issue":"6","key":"57503_CR18","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1038\/s41571-022-00620-6","volume":"19","author":"MJ Pittet","year":"2022","unstructured":"Pittet, M. J., Michielin, O. & Migliorini, D. Clinical relevance of tumour-associated macrophages. Nat. Rev. Clin. Oncol. 19 (6), 402\u2013421 (2022).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"57503_CR19","doi-asserted-by":"publisher","first-page":"756722","DOI":"10.3389\/fimmu.2021.756722","volume":"12","author":"Q Yang","year":"2021","unstructured":"Yang, Q. et al. Single-Cell RNA Sequencing Reveals the Heterogeneity of Tumor-Associated Macrophage in Non-Small Cell Lung Cancer and Differences Between Sexes. Front. Immunol. 12, 756722 (2021).","journal-title":"Front. Immunol."},{"issue":"1","key":"57503_CR20","doi-asserted-by":"publisher","first-page":"29","DOI":"10.3390\/cells14010029","volume":"14","author":"NS Lotsios","year":"2024","unstructured":"Lotsios, N. S. et al. Expression and Regulation of Hypoxia-Inducible Factor Signalling in Acute Lung Inflammation. Cells 14 (1), 29 (2024).","journal-title":"Cells"},{"issue":"1","key":"57503_CR21","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1038\/s41392-023-01332-8","volume":"8","author":"Z Chen","year":"2023","unstructured":"Chen, Z., Han, F., Du, Y., Shi, H. & Zhou, W. Hypoxic microenvironment in cancer: molecular mechanisms and therapeutic interventions. Signal. Transduct. Target. Ther. 8 (1), 70 (2023).","journal-title":"Signal. Transduct. Target. Ther."},{"issue":"1","key":"57503_CR22","doi-asserted-by":"publisher","first-page":"1742","DOI":"10.1038\/s41467-022-29366-6","volume":"13","author":"J Qi","year":"2022","unstructured":"Qi, J. et al. Single-cell and spatial analysis reveal interaction of FAP(+) fibroblasts and SPP1(+) macrophages in colorectal cancer. Nat. Commun. 13 (1), 1742 (2022).","journal-title":"Nat. Commun."},{"key":"57503_CR23","doi-asserted-by":"publisher","first-page":"1528103","DOI":"10.3389\/fimmu.2025.1528103","volume":"16","author":"Y Gu","year":"2025","unstructured":"Gu, Y. et al. The dual role of CXCL9\/SPP1 polarized tumor-associated macrophages in modulating anti-tumor immunity in hepatocellular carcinoma. Front. Immunol. 16, 1528103 (2025).","journal-title":"Front. Immunol."},{"issue":"12","key":"57503_CR24","doi-asserted-by":"publisher","first-page":"e1515","DOI":"10.1002\/ctm2.1515","volume":"13","author":"C Chen","year":"2023","unstructured":"Chen, C. et al. Single-cell and spatial transcriptomics reveal POSTN(+) cancer-associated fibroblasts correlated with immune suppression and tumour progression in non-small cell lung cancer. Clin. Transl Med. 13 (12), e1515 (2023).","journal-title":"Clin. Transl Med."},{"issue":"1","key":"57503_CR25","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/1756-9966-31-26","volume":"31","author":"F Shojaei","year":"2012","unstructured":"Shojaei, F. et al. Osteopontin induces growth of metastatic tumors in a preclinical model of non-small lung cancer. J. Exp. Clin. Cancer Res. 31 (1), 26 (2012).","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"10","key":"57503_CR26","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1007\/s00262-025-04180-3","volume":"74","author":"RT Almgrami","year":"2025","unstructured":"Almgrami, R. T. et al. Single-cell transcriptomic analyses provide insights into SPP1(+) TAM-mediated immune suppression and CD8(+) T cell dysfunction in lung cancer. Cancer Immunol. Immunother. 74 (10), 319 (2025).","journal-title":"Cancer Immunol. Immunother"},{"issue":"1","key":"57503_CR27","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1186\/s13046-025-03393-9","volume":"44","author":"A Ellert-Miklaszewska","year":"2025","unstructured":"Ellert-Miklaszewska, A. et al. 7aaRGD - a novel SPP1\/integrin signaling-blocking peptide reverses immunosuppression and improves anti-PD-1 immunotherapy outcomes in experimental gliomas. J. Exp. Clin. Cancer Res. 44 (1), 132 (2025).","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"1","key":"57503_CR28","doi-asserted-by":"publisher","first-page":"2184130","DOI":"10.1080\/2162402X.2023.2184130","volume":"12","author":"A Valind","year":"2023","unstructured":"Valind, A. et al. Macrophage infiltration promotes regrowth in MYCN-amplified neuroblastoma after chemotherapy. Oncoimmunology 12 (1), 2184130 (2023).","journal-title":"Oncoimmunology"},{"issue":"11","key":"57503_CR29","doi-asserted-by":"publisher","first-page":"5312","DOI":"10.7150\/thno.109097","volume":"15","author":"Q Ge","year":"2025","unstructured":"Ge, Q. et al. Spatially segregated APOE(+) macrophages restrict immunotherapy efficacy in clear cell renal cell carcinoma. Theranostics 15 (11), 5312\u20135336 (2025).","journal-title":"Theranostics"},{"issue":"1","key":"57503_CR30","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1158\/0008-5472.CAN-22-0651","volume":"83","author":"M Perrone","year":"2023","unstructured":"Perrone, M. et al. ATF3 Reprograms the Bone Marrow Niche in Response to Early Breast Cancer Transformation. Cancer Res. 83 (1), 117\u2013129 (2023).","journal-title":"Cancer Res."},{"key":"57503_CR31","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3390\/cancers17193256","volume":"17","author":"MG Pitts","year":"2025","unstructured":"Pitts, M. G., Bryant, L. T., Buoncristiani, M. D. & Rellinger, E. J. MYCN-Driven Metabolic Networks Are a Critical Dependency of High-Risk Neuroblastomas. Cancers (Basel). 17, 19 (2025).","journal-title":"Cancers (Basel)"},{"key":"57503_CR32","doi-asserted-by":"publisher","first-page":"1650161","DOI":"10.3389\/fimmu.2025.1650161","volume":"16","author":"T Fan","year":"2025","unstructured":"Fan, T., Lin, S., Zhou, J., Chen, J. & Wang, L. The feasibility of targeting macrophage for disease treatment: roles of CEBPD. Front. Immunol. 16, 1650161 (2025).","journal-title":"Front. Immunol."},{"issue":"7","key":"57503_CR33","doi-asserted-by":"publisher","first-page":"2646","DOI":"10.21037\/tlcr-2025-244","volume":"14","author":"M Xiao","year":"2025","unstructured":"Xiao, M. et al. Single-cell and spatial transcriptomics profile the interaction of SPP1(+) macrophages and FAP(+) fibroblasts in non-small cell lung cancer. Transl Lung Cancer Res. 14 (7), 2646\u20132669 (2025).","journal-title":"Transl Lung Cancer Res."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-57503-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-57503-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-57503-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T22:54:11Z","timestamp":1787871251000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-57503-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,13]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["57503"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-57503-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,13]]},"assertion":[{"value":"11 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by Ethics Committee of Xinjiang Medical University Affiliated Tumor Hospital (K-2025062).","order":2,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"26992"}}